ArticleCureus2025
Definite Vestibular Paroxysmia Comorbid With Definite Ménière's Disease: A Rare Case Highlighting Diagnostic and Therapeutic Implications.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ménière's disease (MD) is characterized by episodic vertigo lasting 20 minutes to several hours with fluctuating sensorineural hearing loss. Vestibular paroxysmia (VP) involves brief, recurrent vertigo attacks that typically last less than one minute and are often responsive to carbamazepine. While both diseases can present with accompanying auditory symptoms during vertigo attacks, they differ in attack duration and drug responsiveness. Here, we report a case of definite MD that was subsequently complicated by definite VP. A 46-year-old man presented with fluctuating right-sided sensorineural hearing loss and recurrent vertigo episodes lasting about one hour, consistent with definite MD. Gadolinium-enhanced MRI demonstrated significant endolymphatic hydrops in the right vestibule without neurovascular compression. Initial treatment with isosorbide improved vertigo. One year later, he developed multiple brief vertigo spells per day, each lasting about one minute and accompanied by tinnitus and nystagmus. These episodes were unresponsive to isosorbide but resolved rapidly after carbamazepine administration, leading to a diagnosis of comorbid VP. This case illustrates the diagnostic challenge of sequential MD and VP while emphasizing the educational value of recognizing their differences in attack duration and pharmacological response in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.